Skip to content

Should patients with high viral loads and high CD4 cell counts start anti-HIV therapy? (corrected)

Directly administered antiretroviral therapy benefits drug users with adherence problems

Microbicides 2006: Poor adherence reported in some of the microbicide studies

Accurate timing of drug doses improves response to HIV treatment

HIV-positive people with higher viral load have increased risk of bacterial pneumonia

Family support just as good as directly observed therapy for TB treatment, Nepal study finds

Co-packaged AZT/3TC/efavirenz regimen approved for use in PEPFAR programmes

CROI: Do boosted protease inhibitors have a lower risk of treatment failure than other regimens?

Clinical and immunological benefits lasting at least three years reported by large Kenyan antiretroviral programme